NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV
Delisted
NBRV was delisted on the 31st of July, 2023.
29 hedge funds and large institutions have $1.25M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
48% less capital invested
Capital invested by funds: $2.41M → $1.25M (-$1.16M)
Holders
29
Holding in Top 10
1
Calls
$41K
Puts
$6K
Top Buyers
| 1 | +$21.1K | |
| 2 | +$13K | |
| 3 | +$6K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$5.88K |
| 5 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
+$4.08K |
Top Sellers
| 1 | -$255K | |
| 2 | -$214K | |
| 3 | -$140K | |
| 4 |
VF
Virtu Financial
New York
|
-$53.9K |
| 5 |
State Street
Boston,
Massachusetts
|
-$51K |